Skip to main content
. 2024 Mar 28;12(4):750. doi: 10.3390/biomedicines12040750

Figure 4.

Figure 4

Comparison between serum S100A8/A9 levels in patients at onset of disease and control group: (a) in patients with gastrointestinal involvement; (b) in patients with renal disease. (Abbreviations: GI—gastrointestinal involvement. Ctrl.—Control group.).